"As your partner in health, we’re dedicated to making it easier for you to live well—so you can show up for the moments that matter most. To us, people are more than patients. We work together as a team to champion high-quality, low-cost care. Our providers and services span hospitals, clinics and at home settings across Iowa, Illinois and Wisconsin. Our presence in metropolitan and rural communities allows us to innovate through partnerships, organizations outside of healthcare, and our family of team members remains dedicated to shared values that put our people first. Because you matter to this world, and we’ll show you just how much."

During the past decade, Iowa Lutheran Hospital conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 122 clinical trials were completed, i.e. on average, 85.9% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 59 clinical trials were completed. i.e. 84.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iowa Lutheran Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 140 trials, followed by "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "SWOG Cancer Research Network" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "Gynecologic Oncology Group" with 20 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Lutheran Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 131 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Iowa Lutheran Hospital" are "Recurrent Ovarian Carcinoma" (16 trials), "Recurrent Fallopian Tube Carcinoma" (12 trials), "Recurrent Primary Peritoneal Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Iowa Lutheran Hospital" in a lesser frequency.

Most popular intervention types in "Iowa Lutheran Hospital" are "Drug" (221 trials), "Other" (169 trials), "Biological" (108 trials), "Procedure" (68 trials) and "Radiation" (44 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (92 trials), "Quality-of-Life Assessment" (66 trials), "Questionnaire Administration" (46 trials), "Paclitaxel" (41 trials) and "Carboplatin" (33 trials). Other intervention names were less common.

The vast majority of trials in "Iowa Lutheran Hospital" are 200 trials for "All" genders, 62 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Iowa Lutheran Hospital". undefined are not yet recruiting, 66 are recruiting, 97 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in Iowa Lutheran Hospital, 5 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Iowa Lutheran Hospital, 11 "Phase 1" clinical trials were conducted, 130 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".